signs and symptoms may be overshadowed by severe UGIB [2] . Several studies showed that this process is common, especially in critically ill patients [2] [3] [4] [5] . Except for those with more cardiac risk factors and more severe anemia, there is no mutual agreement about other risk factors in this group. High-output heart failure has been noticed in cirrhotic patients and this syndrome is termed cirrhotic cardiomyopathy. Ventricular hyporesponsiveness is revealed when cirrhotic patients are challenged by pharmacologic or physiologic stress [6] . In addition, hemodynamic instability is often noticed in patients with liver cirrhosis and variceal bleeding [7] . This could potentiate (subclinical) heart failure and myocardial injury. Some medications used to treat bleeding varices, including terlipressin and vasopressin, have the potential for aggravating myocardial ischemia because of their coronary artery vasoconstricting effect [8, 9] . However, their impact on myocardial injury during UGIB is generally not recognized.
Troponin I (TnI), which is more frequently used in recent years, is a more rapidly-rising and specific marker and outcome predictor during AMI [10] . It was shown to be a better biologic marker to detect occult myocardial injury during UGIB [5] . Pateron et al showed a frequent elevated TnI (32%) above the lower detection limit in patients with cirrhosis and indicated that it was associated with subclinical left ventricular myocardial injury [11] . The aims of this study were to: (1) evaluate the epidemiology of simultaneous UGIB and myocardial injury using parameters including TnI; and (2) determine the possible risk factors in patients who develop simultaneous myocardial injury.
PATIENTS AND METHODS

Patients
Patients at the emergency department (ED) of Kaohsiung Medical University Hospital during the period from July to December 2004 with the chief complaint of tarry stool passage or blood vomitus were diagnosed with UGIB. This hospital is a tertiary referral medical center in the Kaohsiung metropolitan area of southern Taiwan. All were admitted to the gastrointestinal (GI) ward after stabilization. All UGIB subjects older than 35 years were included. Because myocardial injury is less common in younger and previously healthy patients with minor bleeding, we excluded those with the presence of the following: (1) younger than 35 years; (2) having less than three cardiac risk factors; (3) initial systolic blood pressure (BP) > 100 mmHg; and (4) initial hemoglobin (Hb) > 12 g/dL. Subjects underwent standardized treatment according to current guidelines [7, 12] . Most of them underwent emergent gastroendoscopy within 24 hours, except for those who refused or were contraindicated (irritable patients or with arrhythmia and severe shock). During gastroendoscopic examination, hemostatic strategies were employed if peptic ulcers with exposure vessels or varices with signs of recent bleeding were diagnosed.
Risk factors and outcome
Electrocardiography (ECG) was done on arrival at the ED and 4 hours later. Cardiac enzymes, including creatine kinase (CK), CK-MB, and TnI (Beckman Coulter Ireland, Inc., Fullerton, CA, USA) were checked every 12 hours for three times after admission. The presence of liver cirrhosis was previously diagnosed in our hospital when a typical change in abdominal ultrasound in addition to a long-standing hepatitis history or evidence of hepatic decompensation (elevated bilirubin level, prolonged prothrombin time, presence of varices in gastroendoscopic examination, encephalopathy) were identified. We used the five traditional cardiac risk factors (diabetes, hypertension, first-degree relatives with premature MI [male relatives < 45 years, female relatives < 55 years], hypercholesterolemia, smoking) and also included other commonly associated risk factors (age, male gender, obesity). Previous UGIB history, underlying malignancy and drug use including aspirin, coumadin, nonsteroidal antiinflammatory drug (NSAID) and steroid, and history of smoking and alcoholic beverage drinking were evaluated using a standardized questionnaire.
In our study, mild myocardial injury was defined as the presence of any of the following: serial ST-T deviation in two consecutive leads on ECG; elevated CK-MB > 12 U/L or TnI > 0.2 ng/dL (normal, < 0.02 ng/ dL) [13, 14] . Moderate myocardial injury was defined as the presence of any two of the previously mentioned conditions. Recurrent bleeding was diagnosed and recorded if patients had an increased amount of tarry stool with hemodynamic instability (tachycardia or hypotension) and decreased Hb measurement within 3 days of initial therapy. Such patients underwent gastroendoscopy for revision and hemostasis. Intravenous medication used to control bleeding (omeprazole, vasopressin, terlipressin, or somatostatin), total amount of packed erythrocyte transfusion, length of hospital stay, intensive care unit (ICU) stay and complications including severe infection, respiratory failure, acute renal failure, were also recorded and analyzed. 
Statistical analysis
RESULTS
Prevalence of simultaneous UGIB and myocardial injury
One hundred and eighty-six patients diagnosed with UGIB were admitted to the GI ward via the ED. Twenty-one of them were excluded according to the exclusion criteria and 10 refused to participate in the study. Of the 155 patients (101 men, 54 women; mean age, 64.7 ± 10.4 years; range, 38-94 years) enrolled in this study, 152 underwent emergent endoscopy. The bleeding sources were from peptic ulcer (esophageal, gastric, or duodenal ulcer) in 112 patients, from varices in 25 and from other lesions (esophagitis, acute gastric mucosal lesion, or gastric erosion) in 15 patients (Table 1) . Sixteen (10.6%) had ST-T deviation on ECG. Thirty-nine (25.2%) and 13 (8.4%) had elevated CK-MB and TnI above the upper limit, respectively. In total, 51 (32.9%) had abnormality in any of the three and were defined as developing mild myocardial injury. Twelve (7.74%) patients had simultaneous moderate myocardial injury and two of them were transferred to the ICU due to overt MI. Catecholamines were not used in any of them. Table 2 ). The significant predictors in UGIB patients who developed moderate myocardial injury were the same as the ones for mild myocardial injury by using univariate analysis (data not shown). After adjusting for age, sex, and other significant predictors in univariate analysis, liver cirrhosis and more than three cardiac risk factors remained significant risk factors (Table 2) . Together, the mean BP and pulse rate on arrival, initial Hb and blood urea nitrogen (BUN)/creatinine (Cr) ratio were not significant predictors of the presence of subsequent myocardial injury. Age, gender, diabetes mellitus, hypertension, renal function abnormality (Cr > 1.6 mg/dL), history of malignancy and use of painkillers were not found to be significant risk factors.
Risk factors for UGIB patients who developed mild or moderate myocardial injury
Outcome
One patient was discharged against advice on the 1 st day and was excluded when analyzing the adverse outcome. As shown in Table 3 , it was found that those who developed mild myocardial injury had a including esophageal, gastric, and duodenal ulcers; ‡ including esophagitis, acute gastric mucosal lesion, and gastric erosion. BP = blood pressure; NG = nasogastric; Cr = creatinine; Hct = hematocrit; NSAID = nonsteroidal anti-inflammatory drug.
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longer hospital stay (mean duration = 8.9 ± 6.91 vs. 6.31 ± 2.65 days, p = 0.013) and required more packed erythrocyte transfusion (5.94 ± 4.07 vs. 4.07 ± 3.94, p = 0.007) than those who did not. A higher rebleeding rate (eight cases, 5.19%) was also seen in those with moderate myocardial injury than those without (25% vs. 3.5%, p = 0.01). In those who had recurrent UGIB, five were from benign gastric ulcers, two were from duodenal ulcers, and one was from esophageal varices. None of them had a history of NSAID use. Four patients died; one and two of them had mild and moderate myocardial injury, respectively. One of them had rebleeding.
DISCUSSION
In our study, the prevalence of simultaneous UGIB and moderate myocardial injury (7.74%) is similar to previous studies (0.94-14%) [2] [3] [4] . One of the explanations the color of the fluid during nasogastric tube irrigation. aOR = adjusted odds ratio; CI = confidence interval; CAD = coronary artery disease; NG = nasogastric; Hct = hematocrit.
for the variety in prevalence is that different parameters were used to define myocardial injury in those without chest complaints. In earlier studies, ECG, CK, and CK-MB but not TnI were used to define myocardial injury, and some of them were retrospective studies in which the prevalence might be underestimated. Recent reports showed that TnI is a more sensitive and specific marker for myocardial necrosis or strain [15] . However, elevation of TnI has been reported in various conditions including pulmonary embolism [16] , major trauma [17] , septic shock [18, 19] , and chronic renal insufficiency [20] . It is not always synonymous with infarction or ischemia. The level of significance of TnI elevation depends on the assay cut-off value. In a study of 227 UGIB patients, 12% were found to develop myocardial injury defined as an elevation of TnI (RxL Dimension, Dade Behring, Milan, Italy) above 0.15 ng/dL. The authors also showed that among the potential risk factors such as ECG change, initial BP, and history of coronary artery disease (CAD), only minimum Hb was found to be a significant predictor. Liver cirrhosis and mild renal dysfunction (Cr, 1.5-2.0 mg/dL) were not significantly associated with an elevated TnI [5] . Our study differed in that an integration of biomarkers (TnI and CK-MB) and ECG were used to define myocardial injury. The identified significant predictors were consistent using either one or two abnormalities as an indicator of myocardial injury. A recent report suggested that such an integration will help identify false-positive acute coronary syndrome patients in the ED [21] .
Our study found that cirrhotic patients were probably among the high-risk groups to develop myocardial injury during UGIB. Vasopressin and terlipressin are commonly used to treat bleeding varices in cirrhotic patients and might cause coronary vasocontracting side effects [8, 9] . In contrast, there is no evidence to suggest that somatostatin has coronary side effects. After adjusting for confounders including the use of those two drugs, cirrhosis was still shown to be a significant risk factor. However, vasopressin or terlipressin use was not an independent risk factor for developing myocardial injury. A study investigating 32 patients with liver cirrhosis showed that 10 (32%) had slightly elevated TnI (range, 0.06-0.25 ng/dL) [11] . Echocardiography was done and the authors suggested that elevated TnI was associated with subclinical left ventricular myocardial damage. One of our study's limitations is that we did not check the baseline CK-MB and TnI levels. The finding of a higher prevalence of myocardial injury among the variceal bleeding group (80.0%) than among the ulcer bleeding group (20.5%) could partially be attributed to a higher baseline CK-MB or TnI level in patients with liver cirrhosis. However, in the ulcer bleeding group, fewer patients (6.25%) had underlying cirrhosis, and we still found that those with more CAD risk factors and liver cirrhosis were in the high-risk group to develop myocardial injury. In addition, we used a higher TnI level (0.2 ng/dL) to define the development of myocardial injury. Thus, other factors exist in addition to a higher baseline TnI to explain why cirrhosis is a risk factor of this syndrome. Although the effect of liver cirrhosis on coronary microcirculation is not clear, the cirrhotic heart develops a series of structural and functional abnormalities consisting of diastolic dysfunction and reduced myocardial reactivity during exercise [22, 23] . These provide an explanation as to why cirrhotic patients are more susceptible to myocardial injury during UGIB and physicians should pay more attention to such patients.
The development of concurrent myocardial injury is associated with the amount and acuteness of blood loss, which is difficult to estimate precisely. It was reported that severe postpartum hemorrhage with hypovolemic shock is highly related to concurrent myocardial injury indicated by elevated TnI and ECG change, especially in those treated with catecholamine [24] . The amount of blood loss could be estimated by the presence of hypotension, tachycardia, orthostatic hypotension, and azotemia (BUN > 40 mg/dL or BUN/ Cr > 20). Because it takes hours to achieve full compensation, the initial Hct or Hb measurement is not considered to be a good indicator of severity during acute blood loss. Frequent monitoring and careful fluid resuscitation are recommended. There is still controversy regarding the lowest Hb concentration that can safely be tolerated. One report showed that reversible AMI after blood transfusion was found in elderly patients with massive GIB (mean Hct elevated from 28.9% to 47.7%) [25] . In another study introducing isovolemic reduction of Hb concentration in 55 healthy adults, transient, reversible ST-segment depression occurred in three asymptomatic subjects when it reduced to 5-7 g/dL [26] . In our study, initial and minimum Hct levels (≤ 25% vs. > 25%) were not significant predictors for UGIB patients to develop myocardial injury. However, it is still important to consider the necessity of adequate blood transfusion before performing gastroendoscopy, which further increases heart load.
Only eight of the 154 cases (5.19%) had recurrent UGIB and none of them had a history of NSAID use. Recurrent bleeding occurred more often in patients who developed moderate myocardial injury (25% vs. 3.52%, p = 0.01), in whom antiplatelet or anticoagulation drugs were contraindicated. Three of the four cases of mortality were from the group who developed myocardial injury and one of them had recurrent UGIB. It follows that major complications often occur simultaneously, and treatment of rebleeding or MI should be coupled together. Those who developed moderate myocardial injury (n = 12) tended to have a longer hospital stay than those without. However, the difference was not significant and could be attributed to a smaller case number in this group. Another limitation of this study is that we did not exclude patients who had CK-MB or TnI above normal range on arrival, so it is difficult to tell if myocardial injury develops before, concurrent with, or after UGIB.
In conclusion, UGIB patients with a history of liver cirrhosis and more than three cardiac risk factors had a high risk of simultaneously developing myocardial injury. More adverse outcomes were found in those patients. Monitoring ECG and cardiac enzymes, including TnI, are recommended in highrisk patients, even if no chest complaints are present. Further studies are necessary to investigate the exact mechanisms by which liver cirrhosis precipitates myocardial injury during UGIB. 
